Glenmark Pharmaceuticals Ltd (GLENMARK) – Strategy, SWOT and Corporate Finance Report
- Pages: 60
- Published: September 2023
- Report Code: MLPH29625FSA
Glenmark Pharmaceuticals Ltd (GLENMARK) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Glenmark Pharmaceuticals Ltd (Glenmark) focuses on the discovery and development of new chemical entities (NCEs). It develops and markets branded and generic formulations. The company's formulations business encompasses therapeutic areas such as dermatology, respiratory, and oncology. The company also has presence in other therapeutic areas such as diabetes, cardiovascular and oral contraceptives. The company manufactures and supplies active pharmaceutical ingredients (APIs). Glenmark has manufacturing facilities in India, Argentina, the US and Czech Republic. The company markets its products in North America, Japan, Latin America, Europe, India, Middle East North Africa (MENA), Asia and Russia, among others. Glenmark is headquartered in Mumbai, Maharashtra, India.
Scope
• Detailed information on Glenmark Pharmaceuticals Ltd required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Glenmark Pharmaceuticals Ltd in the form of a SWOT analysis
• An in-depth view of the business model of Glenmark Pharmaceuticals Ltd including a breakdown and examination of key business segments
• News about Glenmark Pharmaceuticals Ltd, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Glenmark Pharmaceuticals Ltd and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Glenmark Pharmaceuticals Ltd as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Glenmark Pharmaceuticals Ltds business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Dr. Reddy's Laboratories Ltd
Viatris Inc
Torrent Pharmaceuticals Ltd
ANI Pharmaceuticals Inc
Alkem Laboratories Ltd
Teva Pharmaceutical Industries Ltd
Aurobindo Pharma Ltd
Pfizer Ltd India
Sun Pharmaceutical Industries Ltd
Emcure Pharmaceuticals Ltd
Divi's Laboratories Ltd
ANI Pharmaceuticals Inc
Teva Pharmaceutical Industries Ltd
Pfizer Ltd India
Dr. Reddy's Laboratories Ltd
Viatris Inc
Mylan Laboratories Ltd
Emcure Pharmaceuticals Ltd
Aurobindo Pharma Ltd
Sun Pharmaceutical Industries Ltd
Divi's Laboratories Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.